GEN Exclusives

More »

GEN News Highlights

Back to Item »

EC Approves Lilly, Amylin, and Alkermes’ Once-Weekly Type 2 Diabetes Drug Bydureon

In the U.S., firms are preparing to submit a response to FDA’s previously issued CRLs by the end of this year.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Value-Pricing Cancer Drugs

Do you think all new cancer drugs awaiting approval should undergo value-pricing?

More »